Abstract
It has been long known that the oncogenic extracellular environment plays an indispensable role in developing and nurturing cancer cell progression and in resistance to standard treatments. However, by how much the biophysical components of tumour extracellular environment contribute to these processes is uncertain. In particular, the topographic environment is scarcely explored. The biophysical modulation of cell behaviour is primarily facilitated through mechanotransduction-associated mechanisms, including focal adhesion and Rho/ROCK signalling. Dysregulation of these pathways is commonly observed in ovarian cancer and, therefore, biophysical modulation of these mechanisms may be of great importance to ovarian cancer development and progression. In this work, aspects of the biophysical environment were explored using a bioimprinting technique. The study showed that topography-mediated substrate sensing delayed cell attachment, however, cell–cell interactions overrode the effect of topography in some cell lines, such as OVCAR-5. Also, 3D topographical cues were shown to modulate the inhibition of focal adhesion and Rho signalling, which resulted in higher MAPK activity in cells on the bioimprints. It was revealed that c-Src is vital to the biophysical modulation of cell proliferation and inhibition of c-Src could downregulate biophysically modulated MAPK activity. This study provides evidence that the biophysical extracellular environment affects key intracellular mechanisms associated with tumourigenicity in ovarian cancer cells.
Highlights
-
Substrate cell-like topography regulates cell attachment in ovarian cancer cells.
-
Biophysical cues influence sensitivity to inhibition of focal adhesion and Rho signalling.
-
Rho regulates growth through MAPK in a cell line dependent manner.
-
Src is vital to the biophysical modulation of cell growth in ovarian cancer cells.
Similar content being viewed by others
References
Cox, T. R., & Erler, J. T. (2011). Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Disease Models & Mechanisms, 4(2), 165–178.
Calvo, F., et al. (2013). Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nature Cell Biology, 15(6), 637–646.
Reid, S. E., et al. (2017). Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium. EMBO Journal, 36(16), 2373–2389.
Ikeda, S., et al. (2003). Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Human Molecular Genetics, 12(9), 1029–1036.
Margadant, C., Cremers, L., Sonnenberg, A., & Boonstra, J. (2013). MAPK uncouples cell cycle progression from cell spreading and cytoskeletal organization in cycling cells. Cellular and Molecular Life Sciences, 70(2), 293–307.
Uroz, M., et al. (2018). Regulation of cell cycle progression by cell-cell and cell-matrix forces. Nature Cell Biology, 20(6), 646–654.
Keselowsky, B. G., Collard, D. M., & García, A. J. (2004). Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials, 25(28), 5947–5954.
Yim, E. K. F., Darling, E. M., Kulangara, K., Guilak, F., & Leong, K. W. (2010). Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials, 31(6), 1299–1306.
Chen, W., Mao, K., Liu, Z., & Dinh-Xuan, A. T. (2014). The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (review). Oncology Letters, 8(5), 1907–1911.
Cavalcanti-Adam, E. A., Volberg, T., Micoulet, A., Kessler, H., Geiger, B., & Spatz, J. P. (2007). Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands. Biophysical Journal, 92(8), 2964–2974.
Schiller, H. B., & Fässler, R. (2013). Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO Reports, 14(6), 509–519.
Li, M., Hong, L., Liao, M., & Guo, G. (2015). Expression and clinical significance of focal adhesion kinase and adrenomedullin in epithelial ovarian cancer. Oncology Letters, 10(2), 1003–1007.
Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014). FAK in cancer: mechanistic findings and clinical applications. Nature Reviews Cancer, 14(9), 598–610.
Stone, R. L., et al. (2014). Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer. Cancer Biology & Therapy, 15(7), 919–929.
Huang, Y. W., Chen, C., Xu, M. M., Li, J. D., Xiao, J., & Zhu, X. F. (2013). Expression of c-Src and phospho-Src in epithelial ovarian carcinoma. Molecular and Cellular Biochemistry, 376(1–2), 73–79.
Xiao, J., Xu, M., Hou, T., Huang, Y., Yang, C., & Li, J. (2015). Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling. Molecular Medicine Reports, 12(3), 3249–3256.
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005). Focal adhesion kinase: in command and control of cell motility. Nature Reviews Molecular Cell Biology, 6(1), 56–68.
Croft, D. R., & Olson, M. F. (2006). The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Molecular and Cellular Biology, 26(12), 4612–4627.
Peng, X., et al. (2008). Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proceedings of the National Academy of Sciences of the USA, 105(18), 6638–6643.
Nagy, T., et al. (2007). Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. Journal of Biological Chemistry, 282(43), 31766–31776.
Lim, Y., et al. (2008). PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. Journal of Cell Biology, 180(1), 187–203.
Zhai, J., et al. (2003). Direct interaction of focal adhesion kinase with p190RhoGEF. Journal of Biological Chemistry, 278(27), 24865–24873.
Tan, L. H., Sykes, P. H., Alkaisi, M. M., & Evans, J. J. (2015). The characteristics of ishikawa endometrial cancer cells are modified by substrate topography with cell-like features and the polymer surface. International Journal of Nanomedicine, 10, 4883–4895.
Sarwar, M., Sykes, P. H., Chitcholtan, K., Alkaisi, M. M., & Evans, J. J. (2019). The extracellular topographical environment influences ovarian cancer cell behaviour. Biochemical and Biophysical Research Communications, 508(4), 1188–1194.
Horton, E. R., et al. (2016). Modulation of FAK and Src adhesion signaling occurs independently of adhesion complex composition. Journal of Cell Biology, 212(3), 349–364.
Ohta, T., et al. (2012). Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1alpha in human ovarian cancer cells. Cancer Biology & Therapy, 13(1), 36–73.
Bolós V., Gasent J. M., López-Tarruella S., & Grande E. (2010). The dual kinase complex Fak-Src as apromising therapeutic target in cancer. Onco Targets and Therapy, 3, 83–97.
Choi, C., Hagvall, S. H., Wu, B. M., Dunn, J. C. Y., Beygui, R. E., & Kim, C. C. J. (2007). Cell interaction with three-dimensional sharp-tip nanotopography. Biomaterials, 28, 1672–1679.
Lim, J. Y., Hansen, J. C., Siedlecki, C. A., Runt, J., & Donahue, H. J. (2005). Human foetal osteoblastic cell response to polymer-demixed nanotopographic interfaces. Journal of the Royal Society Interface, 2(2), 97–108.
Pennisi, C. P., et al. (2011). N anoscale topography reduces fibroblast growth, focal adhesion size and migration-related gene expression on platinum surfaces. Colloids and Surfaces B: Biointerfaces, 85(2), 189–197.
Giannini, M., et al.(2018). Nano-topography: quicksand for cell cycle progression?. Nanomedicine: Nanotechnology, Biology and Medicine, 14(8), 2656–2665.
Tan, L. H., Sykes, P. H., Alkaisi, M. M., & Evans, J. J. (2017). Cell-like features imprinted in the physical nano- and micro-topography of the environment modify the responses to anti-cancer drugs of endometrial cancer cells. Biofabrication, 9(1), 1–10.
Yang, S. P., & Lee, T. M. (2011). The effect of substrate topography on hFOB cell behavior and initial cell adhesion evaluated by a cytodetacher. Journal of Materials Science: Materials in Medicine, 22(4), 1027–1036.
Seo, C. H., Furukawa, K., Montagne, K., Jeong, H., & Ushida, T. (2011). The effect of substrate microtopography on focal adhesion maturation and actin organization via the RhoA/ROCK pathway. Biomaterials, 32(36), 9568–9575.
Seo, C. H., Jeong, H., Furukawa, K. S., Suzuki, Y., & Ushida, T. (2013). The switching of focal adhesion maturation sites and actin filament activation for MSCs by topography of well-defined micropatterned surfaces. Biomaterials, 34(7), 1764–1771.
Lunova, M., et al. (2016). Modulation of collective cell behaviour by geometrical constraints. Integrative Biology, 8(11), 1099–1110.
Wang, X., Jiang, W., Kang, J., Liu, Q., & Nie, M. (2015). Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice. Oncology Reports, 34(2), 891–899.
Schulte, C., et al. (2016). Conversion of nanoscale topographical information of cluster-assembled zirconia surfaces into mechanotransductive events promotes neuronal differentiation. Journal of Nanobiotechnology, 14(1), 1–24.
Dalby, M. J., Gadegaard, N., & Oreffo, R. O. C. (2014). Harnessing nanotopography and integrin-matrix interactions to influence stem cell fate. Nature Materials, 13(6), 558–569.
Marlowe, T. A., Lenzo, F. L., Figel, S. A., Grapes, A. T., & Cance, W. G. (2016). Oncogenic receptor tyrosine kinases directly phosphorylate focal adhesion kinase (FAK) as a resistance mechanism to FAK-kinase inhibitors. Molecular Cancer Therapeutics, 15(12), 3028–3039.
Hamilton, D. W., & Brunette, D. M. (2007). The effect of substratum topography on osteoblast adhesion mediated signal transduction and phosphorylation. Biomaterials, 28(10), 1806–1819.
Brasseur, K., Gévry, N., & Asselin, E. (2017). Chemoresistance and targeted therapies in ovarian and endometrial cancers. Oncotarget, 8(3), 4008–4042.
Nakashima, M., et al. (2011). Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Molecular Cancer, 10, 1–11.
Nakashima, M., Adachi, S., Yasuda, I., Yamauchi, T., Kozawa, O., & Moriwaki, H. (2010). Rho-kinase regulates negatively the epidermal growth factor-stimulated colon cancer cell proliferation. International Journal of Oncology, 36(6), 585–592.
Evans, J. J., Alkaisi, M. M., & Sykes, P. H. (2019). Tumour initiation: a discussion on evidence for a ‘load-trigger’ mechanism. Cell Biochemistry and Biophysics, 77(4), 293–308.
Author information
Authors and Affiliations
Contributions
M.S.: overall execution of the research, paper writing. P.H.S.: clinical input. K.C.: data analysis. J.J.E.: scientific input, paper writing.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sarwar, M., Sykes, P.H., Chitcholtan, K. et al. Deciphering Biophysical Modulation in Ovarian Cancer Cells. Cell Biochem Biophys 79, 375–386 (2021). https://doi.org/10.1007/s12013-020-00964-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-020-00964-9